7/2/2014 7:16:23 AM
EWING, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that the company will host its first Analyst Day on Thursday, July 17, 2014, from 9:00am – 12:00pm ET at the Omni Berkshire Place Hotel in New York City.
Members of Celator's management team will discuss the company's strategic plan aimed at long-term growth, as well as provide updates on its proprietary CombiPlex® technology platform and an overview of lead compound CPX-351, currently in a Phase 3 clinical trial for the treatment of high-risk (secondary) acute myeloid leukemia (AML).
Help employers find you! Check out all the jobs and post your resume.
comments powered by